Boulevard Bio
boulevardbio.com
Biotechnology
Boulevard Bio develops multi-specific antibodies to treat B cell-driven autoimmune diseases using precision immunology. The company focuses on optimizing therapeutic candidates to improve patient outcomes.
Founded
2015
Total Funding
Tens of millions
Total Rounds
1
First Raise
Aug 11, 2026
Latest Raise
Aug 11, 2026
Get notified when Boulevard Bio and companies like it raise
New funding rounds in your inbox every week 路 No noise, all Signal.
Organization Chart
Founders and leadership hierarchy for this company.
Contact details require Sales or Enterprise
All Funding Rounds
| Date | Deal Type | Amount | Lead Investor |
|---|---|---|---|
| 8/11/2026 | |||
Company Performance Metrics
Premium Feature
Upgrade to Premium to view Capital Momentum Score and performance metrics
Boulevard Bio 路 Never miss the next round
Who's raising next?
New funding rounds in your inbox every week 路 Free